Investigating corrected QT prolongation with hydroxychloroquine use among patients with cutaneous sarcoidosis: A multicenter retrospective study - 19/09/24
Doi : 10.1016/j.jaad.2024.06.018
Chinemelum E. Obijiofor, BA a, Michelle Sikora, BS a, b, Lynn Liu, MD a, Marleigh J. Stern, MD a, Kerry M. Hena, MD c, Daniel R. Mazori, MD a, Steven Friedman, MS d, Soutrik Mandal, PhD d, Avrom S. Caplan, MD a, ⁎ 
a The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York
b New York Medical College, Valhalla, New York
c Division of Pulmonary and Critical Care, Department of Medicine, NYU Grossman School of Medicine, New York, New York
d Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, New York
∗Correspondence to: Avrom S. Caplan, MD, The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 222 East 41st St, 16th Floor, New York, NY 10016The Ronald O. Perelman Department of DermatologyNew York University Grossman School of Medicine222 East 41st St, 16th FloorNew YorkNY10016
Key words : cutaneous sarcoidosis, hydroxychloroquine, QTc prolongation, sarcoidosis
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: This study has received approval from the New York University Grossman School of Medicine and Bellevue Institutional Review Board. |
© 2024
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 91 - N° 4
P. 740-742 - ottobre 2024 Ritorno al numero
Articolo precedente
- Historic and continued underrepresentation of the Hispanic/Latino ethnicity among dermatologic clinical trial participants
- Bianca E. Ituarte, Calla Sullivan, Erin X. Wei
- Cross-sectional analysis of state and federal malpractice and medical liability claims for cutaneous energy-based device procedures, 1985 to 2023
- Scott Stratman, Jeffrey S. Dover, Jessica G. Labadie
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?